Screener
Jazz Pharmaceuticals JAZZ Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $11.64B.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's market capitalization?
- Jazz Pharmaceuticals (JAZZ) reported market capitalization of $11.64B in Q1 2026.
- How has Jazz Pharmaceuticals's market capitalization changed year-over-year?
- Jazz Pharmaceuticals's market capitalization increased by 54.4% year-over-year, from $7.54B to $11.64B.
- What is the long-term trend for Jazz Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's market capitalization has grown at a 0.4% compound annual growth rate (CAGR), from $10.15B to $10.33B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Jazz Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude